Michael Mancino, M.D.

Dr. Mancino graduated medical school from Northeastern Ohio Universities College of Medicine. He trained for several years in neurological surgery and eventually completed his training at UAMS in psychiatry in 2004. He is board certified by the American Board of Psychiatry and Neurology as well as the American Board of Preventive Medicine with a specialization in Addiction Medicine. He is a professor at the UAMS Psychiatric Research Institute and currently the Program Director for the Center for Addiction Services and Treatment. He was previously the Medical Director of the Recovery Centers of Arkansas. He focuses his clinical practice on medications for opioid use disorder (MOUD). Dr. Mancino also has an interest in conducting clinical trials for medications development for patients with psychostimulant and opioid addictions and is funded by the Clinical Trials Network on a project designed to improve retention in MOUD treatment for patients with opioid use disorders as Co-I with Dr. Alison Oliveto. Dr. Mancino is passionate about increasing access to MOUD across the state of Arkansas. He works in conjunction with the Arkansas Division of Behavioral Health Services to support prescribers in managing patient with opioid use disorder across the state

2023 Presentation:

This presentation will examine the severity of the opioid epidemic across the nation with an emphasis on its impact in Arkansas. We will explore one of the significant drivers behind relapse, opioid withdrawal. We will discuss the FDA-approved medications for opioid use disorder and understand the rationale, efficacy, and side effects of each of the medications.

Learning Objectives:

• Become familiar with the severity of the opioid crisis in Arkansas and across the nation.
• Become familiar with medications for opioid use disorder.
• Understand the goals of pharmacotherapy for opioid use disorder.